Alnylam Pharmaceuticals, Inc. ALNY announced that the European Commission (EC) has approved a label expansion of its RNAi therapeutic Amvuttra. The EC has now approved Amvuttra for the treatment ...

Bristol Myers Squibb BMY announced that the European Commission (EC) approved a label expansion of the immuno-oncology drug Opdivo (nivolumab). The EC approved the drug as a monotherapy for the ...